Trial intelligence / Profile preview

Ethyol for Esophageal Protection in Limited-Stage Small Cell Lung Cancer

NCT00004176Phase 2Completed

Sponsor
Washington University School of Medicine
Start
Oct 1998
Primary completion
Feb 2001
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of amifostine in radiation-induced esophagitis, sponsored by Washington University School of Medicine. Started Oct 1998; status: completed.

02

Drugs

amifostine
03

Conditions

radiation-induced esophagitis

Beyond the preview

Go deeper on NCT00004176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call